NDRA ENDRA Life Sciences Inc. - Common Stock
NASDAQ · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$6,06
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$2,9652 haftanın en düşüğü
$9,8552 haftanın en yükseği
Piyasa Değeri (MRQ)
$9M
P/E
-0.7
Hisse Başına Kâr
$-8.93
rozetleriniz
52 Haftlık Aralık
$3–$10
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$25
P/E
-0.7
ROE
-376.5%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
NDRA Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$6.06
Piyasa Değeri (MRQ)
$9M
P/E
-0.7
Hisse Başına Kâr
$-8.93
ROE
-376.5%
52 Haftlık Aralık
$3–$10
NDRA Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 07 Kasım 2024 | 1-for-35 | Ters |
| 20 Ağustos 2024 | 1-for-50 | Ters |
| 09 Aralık 2022 | 1-for-20 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2016-12-31 → 2020-12-31
Hisse Başına Kâr$-8.932023-12-31 → 2025-12-31
Serbest Nakit Akışı$-5M2018-12-31 → 2025-12-31
Net kar marjı·2018-12-31 → 2018-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | NDRA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.75Y ort. ≈-0.7 | ≈-0.7 | · | · | |
| F/D (MRQ) | 1.45Y ort. ≈21104.1 | ≈21104.1 | 1.2 | Adil değer | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | -1.45Y ort. ≈-19611.4 | ≈-19611.4 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | -1.45Y ort. ≈-19694.5 | ≈-19694.5 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 3.25Y ort. ≈21104.1 | ≈21104.1 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | NDRA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -169.2%5Y ort. ≈-154.8% | ≈-154.8% | -82.8% | Zayıf | |
| ROE | -376.5%5Y ort. ≈-211.6% | ≈-211.6% | -129.4% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | NDRA | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 7.15Y ort. ≈3.8 | ≈3.8 | 1.8 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 1.0 | · | 1.1 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-7.1%
Sonraki Rapor
Kas 12, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 14, 2026 | $0.06 | $-0.86 | 107.0% |
| 31 Mart 2026 | May 15, 2026 | $-1.09 | $-1.25 | 13.1% |
| 31 Aralık 2025 | $-3.26 | $-1.25 | -159.8% | |
| 30 Eylül 2025 | $-2.10 | $-1.99 | -5.6% | |
| 30 Haziran 2025 | $-1.71 | $-2.32 | 26.1% | |
| 31 Mart 2025 | $-1.86 | $-3.99 | 53.4% | |
| 31 Aralık 2024 | $-7.69 | $-4.18 | -83.8% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $0 | $0 | $6.2K | $351.6K | $515.6K | |
| Cost of Revenue | · | · | · | · | · | $0 | $0 | $0 | $172.8K | · | |
| Gross Profit | · | · | · | · | · | $0 | $0 | $6.2K | $178.8K | $279.7K | |
| R&D Expense | $2M | $3M | $5M | $7M | $5M | $6M | $7M | $5M | $2M | $495.4K | |
| SG&A Expense | $4M | $7M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | |
| Operating Expenses | $6M | $11M | $11M | $13M | $11M | $12M | $11M | $9M | $5M | $2M | |
| Operating Income | $-6M | $-11M | $-11M | $-13M | $-11M | $-12M | $-11M | $-9M | $-5M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $42.6K | $72.0K | |
| Other Non-op | $-1M | $-690.8K | $460.5K | $-21.5K | $-41.5K | $8.8K | $-106.9K | $-48.0K | $-750.9K | · | |
| Pretax Income | $-7M | $-12M | $-10M | $-13M | $-11M | $-12M | $-13M | $-10M | $-5M | $-3M | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-7M | $-12M | $-10M | $-13M | $-11M | $-12M | $-13M | $-10M | $-5M | $-3M | |
| EPS (Basic) | $-8.93 | $-56.94 | · | $-4.56 | $-5.55 | $-0.63 | · | · | · | · | |
| EPS (Diluted) | $-8.93 | $-56.94 | $-2766.85 | · | · | · | · | · | · | · | |
| Shares (Basic) | 787,020 | 202,106 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 787,020 | 202,106 | 3,636 | · | · | · | · | · | · | · | |
| EBITDA | $-6M | $-11M | $-11M | $-13M | $-11M | $-11M | $-11M | $-9M | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $762.4K | $3M | · | $5M | $9M | $7M | $6M | $6M | $6M | $145.0K | |
| Receivables | · | · | · | · | · | · | · | $0 | $6.8K | $0 | |
| Inventory | $0 | $0 | $3M | $3M | $1M | $589.6K | $113.4K | $59.4K | $191.7K | $40.1K | |
| Prepaid Expense | $205.6K | $204.2K | $198.9K | $490.3K | $1M | $390.8K | $116.7K | $145.4K | $67.5K | $0 | |
| Other Current Assets | · | · | · | · | · | $6.0K | $130.7K | $273.3K | $14.2K | $10.5K | |
| Current Assets | $968.0K | $3M | $3M | $5M | $12M | $8M | $7M | $7M | $6M | $195.6K | |
| PP&E (Net) | $42.5K | $69.3K | $111.8K | $235.7K | $131.1K | $212.2K | $236.3K | $273.2K | $241.5K | $295.2K | |
| PP&E (Gross) | · | · | $587.0K | $738.7K | $605.2K | $718.9K | $679.2K | $679.2K | $579.2K | $571.3K | |
| Accum. Depreciation | $679.9K | $635.8K | $600.4K | $643.7K | $581.8K | $585.9K | $486.5K | $405.9K | $337.6K | $276.1K | |
| Other Non-current Assets | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | · | · | · | |
| Total Assets | $4M | $4M | $7M | $9M | $13M | $9M | $7M | $7M | $6M | $490.8K | |
| Accounts Payable | $383.0K | $269.7K | $360.4K | $614.0K | $791.1K | $402.9K | $1M | $631.5K | $780.3K | $227.7K | |
| Accrued Liabilities | $161.9K | · | · | · | · | · | · | · | $0 | $72.0K | |
| Short-term Debt | · | $0 | $28.5K | $28.5K | · | · | · | · | $0 | $50.0K | |
| Current Liabilities | $751.0K | $605.2K | $903.1K | $2M | $2M | $986.7K | $2M | $974.6K | $848.2K | $1M | |
| Capital Leases | $363.0K | $487.5K | $192.1K | $365.9K | $518.1K | $271.9K | $342.8K | $0 | · | · | |
| Total Liabilities | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $974.6K | $848.2K | $1M | |
| Long-term Debt | · | $0 | $0 | $0 | $546.6K | · | · | · | · | · | |
| Total Debt | · | $0 | $28.5K | · | · | · | · | · | · | · | |
| Common Stock | $116 | $53 | $1 | $317 | $212 | $3.4K | $842 | $742 | $392 | $72 | |
| Paid-in Capital | $113M | $106M | $98M | $89M | $79M | $64M | $50M | $34M | $23M | $12M | |
| Retained Earnings | $-110M | $-103M | $-92M | $-82M | $-69M | $-57M | $-45M | $-28M | $-18M | $-13M | |
| Stockholders' Equity | $2M | $3M | $6M | $7M | $11M | $7M | $5M | $6M | $5M | $-893.8K | |
| Liabilities + Equity | $4M | $4M | $7M | $9M | $13M | $9M | $7M | $7M | $6M | $490.8K | |
| Shares Outstanding | 1,176,477 | 536,908 | 5,937 | 3,169,103 | 2,127,725 | 34,049,704 | 8,421,401 | 7,422,642 | 3,923,027 | 723,335 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $44.0K | $46.5K | $123.7K | $96.7K | $116.2K | $99.3K | $80.6K | $68.3K | $61.5K | $64.9K | |
| Stock-based Comp | $329.4K | $571.9K | $996.4K | $1M | $1M | $2M | · | · | · | · | |
| Deferred Tax | · | · | $0 | $0 | $0 | $0 | · | · | · | · | |
| Other Non-cash | $1M | · | · | $-886.8K | $-1M | $879.6K | $5M | $2M | · | · | |
| Operating Cash Flow | $-5M | $-7M | $-10M | $-13M | $-11M | $-11M | $-9M | $-8M | $-3M | $-1M | |
| CapEx | $17.3K | $16.0K | $33.9K | $202.6K | $45.0K | $75.3K | $43.6K | $100.0K | $7.9K | · | |
| Investing Cash Flow | $-3M | $-12.8K | $-24.7K | $-202.6K | $-45.0K | $-75.3K | $-43.6K | $-100.0K | $-7.9K | $0 | |
| Stock Issued | $1M | $5M | $6M | $8M | $11M | $7M | $125.0K | $8M | $9M | $5.0K | |
| Net Stock Activity | $1M | $1M | $6M | $8M | $11M | $7M | $125.0K | $8M | · | · | |
| Financing Cash Flow | $6M | $8M | $8M | $8M | $13M | $12M | $8M | $9M | $9M | $1M | |
| Taxes Paid | · | · | $0 | $0 | · | $0 | $0 | $0 | $0 | · | |
| Free Cash Flow | $-5M | $-7M | $-10M | $-13M | $-11M | $-11M | $-9M | $-8M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 100.0% | · | · | |
| Operating Margin | · | · | · | · | · | · | · | -146080.5% | · | · | |
| Net Margin | · | · | · | · | · | · | · | -158669.6% | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | -158669.6% | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -144974.0% | · | · | |
| ROA | -169.2% | -205.4% | -125.5% | -119.0% | · | -147.1% | -184.8% | -146.8% | · | · | |
| ROE | -376.5% | -251.1% | -185.3% | -151.4% | -93.8% | -223.2% | -431.8% | -338.4% | · | · | |
| ROIC | · | -422.5% | -185.0% | -182.6% | -106.6% | -160.4% | -227.8% | -144.3% | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 5.7 | 3.4 | 5.0 | · | 8.3 | 3.2 | 7.1 | · | · | |
| Quick Ratio | 1.0 | · | · | 2.9 | · | 7.3 | 3.0 | 6.6 | · | · | |
| Debt / Equity | · | 0.0 | 0.0 | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Receivables Turnover | · | · | · | · | · | · | · | 1.8 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.92 | $4.77 | $0.54 | $2.27 | $0.25 | $0.21 | $0.57 | $0.84 | · | · | |
| Cash Flow / Share | $-6.58 | $-36.62 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.65 | · | · | $1.54 | $0.22 | $0.21 | $0.73 | $0.87 | · | · | |
| EPS (TTM) | $-8.93 | $-56.94 | $-2766.85 | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.2K | $351.6K | · | |
| Net Income TTM | $-7M | $-12M | $-10M | $-13M | $-11M | $-12M | $-13M | $-10M | $-5M | · | |
| Market Cap | $5M | $3M | $38.55B | $22.57B | $1.03T | $893.80B | $495.18B | $389.69B | · | · | |
| P/E | -0.5 | -0.1 | -1.3 | · | · | · | · | · | · | · | |
| P/S | · | · | · | · | · | · | · | 63117704.1 | · | · | |
| P/B | 2.4 | 1.3 | 6811.7 | 3133.0 | 95571.8 | 124670.8 | 104014.4 | 62368.1 | · | · | |
| P / Tangible Book | 2.4 | 1.3 | 6811.7 | 3133.0 | 95571.8 | 124670.7 | · | · | · | · | |
| P / Cash Flow | -1.0 | -0.5 | -4036.9 | -1767.7 | -92666.3 | -83171.0 | -57653.6 | -50592.6 | · | · | |
| P / FCF | -1.0 | -0.5 | -4022.6 | -1740.1 | -92292.9 | -82592.0 | -57362.5 | -49944.2 | · | · | |
| Earnings Yield | -197.1% | -909.6% | -74.6% | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $233.7K | $776.4K | $508.1K | $432.1K | $381.1K | $528.7K | $638.0K | $794.4K | $716.4K | $1M | $579.4K | $2M | $1M | $1M | $2M | $2M | |
| SG&A Expense | $1M | $1M | $1M | $893.3K | $851.2K | $871.6K | $4M | $631.4K | $1M | $2M | $730.6K | $1M | $1M | $1M | $1M | $1M | |
| Operating Expenses | $1M | $2M | $2M | $1M | $1M | $1M | $4M | $2M | $2M | $3M | $1M | $3M | $3M | $3M | $3M | $3M | |
| Operating Income | $-1M | $-2M | $-2M | $-1M | $-1M | $-1M | $-4M | $-2M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Other Non-op | $2M | $862.3K | $-1M | $42.0K | $75.2K | $433.0K | $-762.9K | $65.5K | $1.7K | $4.8K | $47.9K | $-28.2K | $437.4K | $3.4K | $23.8K | $-23.0K | |
| Pretax Income | $159.9K | $-1M | $-3M | $-2M | $-1M | $-1M | $-4M | $-2M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Income Tax | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $159.9K | $-1M | $-3M | $-2M | $-1M | $-1M | $-4M | $-2M | $-2M | $-3M | $-1M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $0.12 | $-1.09 | $-3.25 | $-2.10 | $-1.71 | $-1.86 | $25.20 | $-9.54 | · | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.06 | $-1.09 | $-3.25 | $-2.10 | $-1.71 | $-1.86 | $25.20 | $-9.54 | · | · | · | · | · | · | · | · | |
| Shares (Basic) | 1,324,046 | 1,199,586 | · | 761,218 | 717,107 | 557,582 | · | 246,816 | · | · | · | · | · | · | · | · | |
| Shares (Diluted) | 2,475,261 | 1,199,586 | · | 761,218 | 717,107 | 557,582 | · | 246,816 | · | · | · | · | · | · | · | · | |
| EBITDA | $-1M | $-2M | · | $-1M | $-1M | $-1M | · | $-2M | $-2M | $-3M | · | $-3M | $-3M | $-3M | · | $-3M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $356.5K | $762.4K | $794.0K | · | · | $3M | · | · | · | · | · | $5M | $2M | · | $8M | |
| Inventory | · | · | $0 | $0 | $0 | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Prepaid Expense | $47.1K | $180.2K | $205.6K | $254.7K | $44.3K | $115.3K | $204.2K | $217.1K | $312.7K | $135.8K | $198.9K | $305.9K | $506.9K | $428.5K | $490.3K | $914.3K | |
| Current Assets | $6M | $536.7K | $968.0K | $1M | $2M | $2M | $3M | $5M | $7M | $1M | $3M | $6M | $8M | $6M | $5M | $12M | |
| PP&E (Net) | $43.5K | $33.0K | $42.5K | $52.6K | $63.4K | $72.8K | $69.3K | $80.3K | $91.8K | $111.5K | $111.8K | $160.8K | $192.9K | $228.1K | $235.7K | $230.6K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $580.0K | $580.0K | $591.0K | · | $658.7K | $658.7K | $765.7K | $738.7K | $733.5K | |
| Accum. Depreciation | $697.5K | $689.4K | $679.9K | $669.8K | · | $649.6K | $635.8K | $624.8K | $613.3K | $604.6K | $600.4K | $638.5K | $606.4K | $678.2K | $643.7K | $646.3K | |
| Other Non-current Assets | $6.0K | $6.0K | $6.0K | $6.0K | · | · | $6.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $8M | $3M | $4M | $2M | $3M | $3M | $4M | $8M | $10M | $5M | $7M | $8M | $9M | $7M | $9M | $12M | |
| Accounts Payable | $465.0K | $456.8K | $383.0K | $252.5K | $282.0K | $223.6K | $269.7K | $279.4K | $300.4K | $521.6K | $360.4K | $419.1K | $414.9K | $524.0K | $614.0K | $636.7K | |
| Accrued Liabilities | $10.0K | $92.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $0 | $0 | $28.5K | $28.5K | $28.5K | · | $28.5K | · | |
| Current Liabilities | $786.6K | $835.4K | $751.0K | $800.3K | $576.6K | $565.8K | $605.2K | $814.0K | $1M | $1M | $903.1K | $2M | $2M | $2M | $2M | $2M | |
| Capital Leases | $290.6K | $327.3K | $363.0K | $396.5K | $429.3K | $461.2K | $487.5K | $49.8K | $98.4K | $145.8K | $192.1K | $237.2K | $281.2K | $324.1K | $365.9K | $405.8K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $0 | $0 | · | $281.2K | $324.1K | $0 | $434.3K | |
| Total Debt | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $28.5K | $28.5K | · | · | · | |
| Common Stock | $148 | $122 | $116 | $77 | $74 | $55 | $53 | $53 | $7.2K | $1.1K | $1 | $841 | $748 | $317 | $317 | $6.3K | |
| Paid-in Capital | $118M | $114M | $113M | $107M | $107M | $106M | $106M | $106M | $106M | $98M | $98M | $96M | $94M | $89M | $89M | $89M | |
| Retained Earnings | $-112M | $-112M | $-110M | $-107M | $-106M | $-104M | $-103M | $-99M | $-97M | $-95M | $-92M | $-90M | $-87M | $-85M | $-82M | $-79M | |
| Stockholders' Equity | $6M | $2M | $2M | $171.4K | $1M | $2M | $3M | $7M | $9M | $4M | $6M | $5M | $7M | $4M | $7M | $10M | |
| Liabilities + Equity | $8M | $3M | $4M | $2M | $3M | $3M | $4M | $8M | $10M | $5M | $7M | $8M | $9M | $7M | $9M | $12M | |
| Shares Outstanding | 1,499,838 | 1,240,751 | 1,176,477 | 786,902 | 752,390 | 562,213 | 536,908 | 534,863 | 72,439,526 | 10,914,447 | 5,937 | 8,411,777 | 7,481,603 | 3,169,103 | 3,169,103 | 63,174,455 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.2K | $9.5K | $10.1K | $10.8K | $9.4K | $13.8K | $11.0K | $11.5K | $8.7K | $15.3K | $21.9K | $32.1K | $35.3K | $34.5K | $32.1K | $23.8K | |
| Stock-based Comp | $541.9K | $574.5K | $12.9K | $144.7K | $39.5K | $83.0K | $104.7K | $-36.8K | $186.6K | $317.5K | $250.6K | $252.7K | $255.9K | $237.3K | $290.8K | $309.2K | |
| Other Non-cash | · | $-392.2K | · | · | · | · | · | · | · | · | · | · | · | $164.1K | · | · | |
| Operating Cash Flow | $-927.6K | $-1M | $-2M | $-1M | $-1M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M | $-3M | $-3M | |
| CapEx | · | · | $0 | $0 | $0 | $17.3K | $0 | $0 | $-11.0K | $27.0K | $6.9K | $0 | $0 | $27.0K | $38.6K | $14.9K | |
| Investing Cash Flow | $2M | $450.0K | $-3M | $0 | $0 | $-17.3K | $0 | $0 | $11.0K | $-23.8K | $2.3K | $0 | $0 | $-27.0K | $-38.6K | $-14.9K | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $-28.5K | · | · | · | · | · | · | |
| Stock Issued | $93.9K | $263.7K | $65.6K | $149.5K | $857.4K | $145.8K | $4M | $0 | $728.5K | $420.0K | $656.8K | $1M | $5M | $0 | $0 | $0 | |
| Net Stock Activity | · | $263.7K | · | · | · | $145.8K | · | · | · | $420.0K | · | · | · | $0 | · | · | |
| Financing Cash Flow | $4M | $263.7K | $5M | $149.5K | $857.4K | $145.8K | $0 | $1.7K | $7M | $468.9K | $2M | $1M | $5M | $0 | $0 | $0 | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | · | $2M | $-3M | · | $-3M | |
| Taxes Paid | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Free Cash Flow | · | · | · | · | · | $-1M | · | · | · | $-2M | · | · | · | $-3M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 3.0% | -39.7% | · | -30.9% | -18.5% | -25.2% | · | -29.5% | -22.7% | -47.4% | · | -31.1% | -20.8% | -33.5% | · | -24.9% | |
| ROE | 4.1% | -74.1% | · | -47.1% | -23.4% | -38.0% | · | -39.9% | -28.0% | -67.7% | · | -40.3% | -25.2% | -43.4% | · | -29.4% | |
| ROIC | · | · | · | · | -88.3% | -83.8% | · | -22.9% | -24.8% | -75.2% | · | -59.9% | -43.0% | -65.3% | · | -33.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.1 | 0.6 | · | 1.3 | 3.2 | 3.9 | · | 6.1 | 5.0 | 1.0 | · | 2.9 | 4.0 | 3.0 | · | 6.8 | |
| Quick Ratio | 2.2 | 0.4 | · | 1.0 | · | · | · | · | · | · | · | · | 2.4 | 1.3 | · | 4.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.21 | $1.44 | · | $0.22 | $1.96 | $3.12 | · | $12.35 | $0.12 | $0.34 | · | $0.62 | $0.93 | $1.42 | · | $0.16 | |
| Cash Flow / Share | · | $-0.93 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.16 | $0.29 | · | $1.01 | · | · | · | · | · | · | · | · | $0.64 | $0.74 | · | $0.13 | |
| EPS (TTM) | $-6.38 | $-8.15 | · | $19.53 | $12.09 | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-6M | $-7M | · | $-8M | $-9M | $-10M | · | $-9M | $-10M | $-10M | · | $-12M | $-12M | $-13M | · | $-13M | |
| Market Cap | $8M | $6M | · | $4M | $3M | $2M | · | $4M | $12.30B | $11.08B | · | $16.34B | $18.33B | $12.70B | · | $676.60B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | $18.33B | · | · | · | |
| P/E | -0.8 | -0.6 | · | 0.3 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 1.3 | 3.2 | · | 24.7 | 1.8 | 1.3 | · | 0.6 | 1367.2 | 2995.6 | · | 3144.5 | 2644.8 | 2822.9 | · | 66311.5 | |
| P / Tangible Book | 1.3 | 3.2 | · | 24.7 | 1.8 | 1.3 | · | 0.6 | 1367.2 | 2995.6 | · | 3144.5 | 2644.8 | 2822.9 | · | 66311.5 | |
| P / Cash Flow | · | -5.2 | · | · | · | -1.8 | · | · | · | -5166.3 | · | · | · | -5066.2 | · | · | |
| Earnings Yield | -119.7% | -175.3% | · | 363.0% | 344.4% | · | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-7M | $-12M | $-10M | $-13M | $-11M |
| Seyreltilmiş Hisse Başı Kâr | $-8.93 | $-56.94 | $-2766.85 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | 0.0 | 0.0 | · | · |
| Cari Oran | 1.3 | 5.7 | 3.4 | 5.0 | · |
| Cari Oran | 1.0 | · | · | 2.9 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-5M | $-7M | $-10M | $-13M | $-11M |
Kurumsal Sahipler (13F) 11 dosya · $878K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
11
Tutulan Değer
$878K
Yeni pozisyonlar
3
Çıkan pozisyonlar
1
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 3 (-1 önceki Ç'ye göre) | 1 (-1 önceki Ç'ye göre) | 2 (+1 önceki Ç'ye göre) | 2 (+1 önceki Ç'ye göre) | +64K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Altium Capital Management LLC | $315.920 | 59.272 | 36,00% | Hisse senetleri |
| CITADEL ADVISORS LLC | $159.495 | 29.924 | 18,17% | Hisse senetleri |
| CITIZENS FINANCIAL GROUP INC/RI | $151.372 | 28.400 | 17,25% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $79.470 | 14.910 | 9,06% | Hisse senetleri |
| VANGUARD GROUP INC | $58.604 | 12.937 | 6,68% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $53.945 | 10.121 | 6,15% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $39.117 | 7.339 | 4,46% | Hisse senetleri |
| MORGAN STANLEY | $18.900 | 3.546 | 2,15% | Hisse senetleri |
| UBS Group AG | $362 | 68 | 0,04% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $309 | 58 | 0,04% | Hisse senetleri |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $101 | 19 | 0,01% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Anthony DiGiandomenico ×2 başvurular | 29 Haziran 2026 | 9,90% | Değişiklik | M&A / satış | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 12 içeriden öğrenenler · 7 yöneticiler · 6 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Alexander Y Tokman | Chief Executive Officer | 02 Mart 2026 A | 101.926 | 0 | 0 | $0 |
| Francois Roger Michelon | Chief Executive Officer | 30 Ocak 2023 A | 97.191 | 0 | 0 | $0 |
| Richard Jacroux | Chief Financial Officer | 02 Mart 2026 A | 33.461 | 0 | 0 | $0 |
| David R. Wells | Chief Financial Officer | 05 Nisan 2021 A | 80.003 | 0 | 0 | $0 |
| Michael Milos Thornton | Chief Technology Officer | 18 Mayıs 2023 P | 34.139 | 0 | 0 | $0 |
| Irina Pestrikova | Senior Director, Finance | 30 Ocak 2023 A | · | 0 | 0 | $0 |
| Renaud Bertrand Maloberti | Chief Commercial Officer | 28 Mart 2022 A | 1.580 | 0 | 0 | $0 |
| Lou Basenese | Yönetim kurulu üyesi | 21 Ocak 2026 A | 65.709 | 0 | 0 | $0 |
| Michael Harsh | Yönetim kurulu üyesi | 21 Ocak 2026 A | 65.710 | 0 | 0 | $0 |
| Anthony DiGiandomenico | Yönetim kurulu üyesi | 21 Ocak 2026 A | 136.589 | 0 | 0 | $0 |
| Sanjiv Sam Gambhir | Yönetim kurulu üyesi | 09 Nisan 2020 A | 42.857 | 0 | 0 | $0 |
| UBS Group AG | · | 27 Ağustos 2024 P | 146.012 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 1 ETF tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 7.339 SH | 19 Ağustos 2026 | Günlük |
NDRA Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$25.00
+312,5%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-10-04Ortalama hedef $25.00 +312,5%
Düşük$25.00
Ortalama$25.00
Yüksek$25.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| NDRA | $5M | -0.5 | · | · | -376.5% | · |
| AEMD | $3M | -0.2 | · | · | -134.5% | · |
| NMTC | · | -9.9 | 163.5% | · | · | · |
| BMRA | · | -1.8 | -16.2% | · | · | · |
| CODX | $11M | -0.1 | -84.1% | -7533.6% | -151.8% | 64.3% |
| AMIX | · | · | · | · | · | · |
| INBS | $7M | -0.3 | 38.1% | -294.9% | -292.2% | 48.6% |
| NVNO | $210.6K | -0.0 | · | · | -64.7% | · |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026